Cargando…
Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application
ABSTRACT: The oncolytic rodent protoparvovirus H-1PV has been successfully used in phase I/II clinical trials to treat recurrent glioblastoma multiforme and pancreatic cancer. The present work focuses on the stability and environmental safety of the H-1PV drug product from production up to its use i...
Autores principales: | Frehtman, Veronika, Wohlfarth, Daniel, Müller, Marcus, Krebs, Ottheinz, Leuchs, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345020/ https://www.ncbi.nlm.nih.gov/pubmed/37209160 http://dx.doi.org/10.1007/s00253-023-12521-4 |
Ejemplares similares
-
Upstream process optimization and micro- and macrocarrier screening for large-scale production of the oncolytic H-1 protoparvovirus
por: Wohlfarth, Daniel, et al.
Publicado: (2021) -
A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles
por: Leuchs, Barbara, et al.
Publicado: (2017) -
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
por: Göbel, Sven, et al.
Publicado: (2022) -
Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks
por: Couto, Pedro Silva, et al.
Publicado: (2023) -
Germinality does not necessarily define mAb expression and thermal stability
por: Schwaigerlehner, Linda, et al.
Publicado: (2019)